In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Thermo Fisher pays $1.7bn for gene therapy manufacturer Brammer Bio

Executive Summary

In the third major deal this quarter in which a gene therapy manufacturer has been acquired, Thermo Fisher Scientific Inc. bought privately held Brammer Bio Inc. for $1.7bn.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register